114 related articles for article (PubMed ID: 21204038)
1. Integrative systems biology approaches to identify and prioritize disease and drug candidate genes.
Kaimal V; Sardana D; Bardes EE; Gudivada RC; Chen J; Jegga AG
Methods Mol Biol; 2011; 700():241-59. PubMed ID: 21204038
[TBL] [Abstract][Full Text] [Related]
2. Identifying disease-causal genes using Semantic Web-based representation of integrated genomic and phenomic knowledge.
Gudivada RC; Qu XA; Chen J; Jegga AG; Neumann EK; Aronow BJ
J Biomed Inform; 2008 Oct; 41(5):717-29. PubMed ID: 18755295
[TBL] [Abstract][Full Text] [Related]
3. CGI: a new approach for prioritizing genes by combining gene expression and protein-protein interaction data.
Ma X; Lee H; Wang L; Sun F
Bioinformatics; 2007 Jan; 23(2):215-21. PubMed ID: 17098772
[TBL] [Abstract][Full Text] [Related]
4. Gene prioritization through genomic data fusion.
Aerts S; Lambrechts D; Maity S; Van Loo P; Coessens B; De Smet F; Tranchevent LC; De Moor B; Marynen P; Hassan B; Carmeliet P; Moreau Y
Nat Biotechnol; 2006 May; 24(5):537-44. PubMed ID: 16680138
[TBL] [Abstract][Full Text] [Related]
5. Web tools for the prioritization of candidate disease genes.
Oti M; Ballouz S; Wouters MA
Methods Mol Biol; 2011; 760():189-206. PubMed ID: 21779998
[TBL] [Abstract][Full Text] [Related]
6. Integrative mining of traditional Chinese medicine literature and MEDLINE for functional gene networks.
Zhou X; Liu B; Wu Z; Feng Y
Artif Intell Med; 2007 Oct; 41(2):87-104. PubMed ID: 17804209
[TBL] [Abstract][Full Text] [Related]
7. Prioritizing genes of potential relevance to diseases affected by sex hormones: an example of myasthenia gravis.
Kaur M; Schmeier S; MacPherson CR; Hofmann O; Hide WA; Taylor S; Willcox N; Bajic VB
BMC Genomics; 2008 Oct; 9():481. PubMed ID: 18851734
[TBL] [Abstract][Full Text] [Related]
8. A systems biology approach to drug discovery.
Zhu J; Zhang B; Schadt EE
Adv Genet; 2008; 60():603-35. PubMed ID: 18358334
[TBL] [Abstract][Full Text] [Related]
9. Syndrome to gene (S2G): in-silico identification of candidate genes for human diseases.
Gefen A; Cohen R; Birk OS
Hum Mutat; 2010 Mar; 31(3):229-36. PubMed ID: 20052752
[TBL] [Abstract][Full Text] [Related]
10. Global risk transformative prioritization for prostate cancer candidate genes in molecular networks.
Chen L; Tai J; Zhang L; Shang Y; Li X; Qu X; Li W; Miao Z; Jia X; Wang H; Li W; He W
Mol Biosyst; 2011 Sep; 7(9):2547-53. PubMed ID: 21735017
[TBL] [Abstract][Full Text] [Related]
11. Integrating genetic, functional genomic, and bioinformatics data in a systems biology approach to complex diseases: application to schizophrenia.
Middleton FA; Rosenow C; Vailaya A; Kuchinsky A; Pato MT; Pato CN
Methods Mol Biol; 2007; 401():337-64. PubMed ID: 18368374
[TBL] [Abstract][Full Text] [Related]
12. Conceptual thinking for in silico prioritization of candidate disease genes.
Tiffin N
Methods Mol Biol; 2011; 760():175-87. PubMed ID: 21779997
[TBL] [Abstract][Full Text] [Related]
13. A GMM-IG framework for selecting genes as expression panel biomarkers.
Wang M; Chen JY
Artif Intell Med; 2010; 48(2-3):75-82. PubMed ID: 20004087
[TBL] [Abstract][Full Text] [Related]
14. New insight into the genes susceptible to asthma.
Gu ML; Dong XQ; Zhao J
J Asthma; 2010 Mar; 47(2):113-6. PubMed ID: 20170315
[TBL] [Abstract][Full Text] [Related]
15. Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia.
Williams M
Curr Opin Investig Drugs; 2003 Jan; 4(1):31-6. PubMed ID: 12625025
[TBL] [Abstract][Full Text] [Related]
16. Neurological disease: are systems approaches the way forward?
Le Novère N
Pharmacopsychiatry; 2008 Sep; 41 Suppl 1():S28-31. PubMed ID: 18756417
[TBL] [Abstract][Full Text] [Related]
17. Gene Ontology analysis in multiple gene clusters under multiple hypothesis testing framework.
Zhong S; Xie D
Artif Intell Med; 2007 Oct; 41(2):105-15. PubMed ID: 17913480
[TBL] [Abstract][Full Text] [Related]
18. Recent approaches to the prioritization of candidate disease genes.
Doncheva NT; Kacprowski T; Albrecht M
Wiley Interdiscip Rev Syst Biol Med; 2012; 4(5):429-42. PubMed ID: 22689539
[TBL] [Abstract][Full Text] [Related]
19. Pathways and promoter networks analysis provides systems topology for systems biology approaches.
Nelson PJ; Werner T
Semin Nephrol; 2010 Sep; 30(5):477-86. PubMed ID: 21044759
[TBL] [Abstract][Full Text] [Related]
20. Computational systems biology in drug discovery and development: methods and applications.
Materi W; Wishart DS
Drug Discov Today; 2007 Apr; 12(7-8):295-303. PubMed ID: 17395089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
